Chelsea Luxen

CEO & Co-founder - BS, MBA

With over nine years of experience in the MedTech industry and six years specifically in wound care, I’ve developed a deep understanding of the market and the critical challenges we face in this field.

As CEO, my primary focus is on steering the strategic direction of ParaNano Wound Care. I’m committed to ensuring that every product we develop is not only innovative but also addresses the real-world needs of patients and healthcare providers. I believe in the power of collaboration and work to empower my team, fostering a culture of creativity and problem-solving that drives our success.

My expertise in new product development, business growth, customer discovery, and project management has been crucial in helping us secure significant funding. We’ve achieved milestones such as an SBIR Phase I Contract with the DHA in 2022 and an Oklahoma Applied Research Support Grant in 2023, which have been pivotal in our journey.

I’m deeply passionate about addressing major medical gaps, particularly in infection detection. My mission is to create products that make a tangible difference in patients' lives, and this drives everything we do at ParaNano Wound Care. I’m proud to lead a team that shares this vision, and together, we’re pushing the boundaries of what’s possible in wound care, setting new standards for innovation and impact.

https://www.linkedin.com/in/chelsea-luxen-mba-249234b4/

Maurice
haff

CTO & Co-founder - BS, ME, MBA

CTO & Co- founder of ParaNano Wound Care, LLC with 40+ years of entrepreneurship experience, 15 years in Med Tech, and 5 years in wound care. He has launched and sold 3 companies and has proven experience in new product development, patent generation and writing, and business development, and grant writing. He is a registered patent agent, writer of all the patents associated with our technology exclusively licensed from our university partners (7 patents and 3 applications), and named inventor on the manufacturing patents needed for product generation. Maurice is passionate about solving problems with novel solutions.

https://www.linkedin.com/in/maurice-haff-educator-entrepreneur-ip-professional-68ab1710/

Ronald
Scott

cmo & wound care advisor - md

Provides the perspective of wound care clinicians.  Dr. Scott has held an ownership interest in the company since 2019.  He has 35 years of experience as a practicing wound care certified physician. Dr. Scott founded the Wound Care Clinic of North Dallas Texas in 1985, where he established the first comprehensive and fully integrated wound treatment facility in the North Texas area and one of the first such facilities in the United States. He pioneered the field of wound care as a distinct medical subspecialty and assisted numerous colleagues in forming similar wound treatment units to help patients across the USA and around the world.  Dr. Scott serves as Chief Medical Officer and clinical advisor.

mark hastings

Director of Distribution
& HCPCS Advisor

Provided Matching Funds & support on behalf of his companies. Chief Executive Officer at Impact Medical Services and a sister wound care product distribution company, AWC Medical in Kansas City, and is the creator of HealOmni. Mr. Hastings has extensive experience in wound care product commercialization, including obtaining HCPCS codes required for CMS reimbursement of medical product purchases by clinicians required for wound care procedures. He strives to lead Impact Medical into a national brand through their unique Part B and NPWT programs. Through these he is putting an emphasis on ongoing education, and taking the "Negative" out of Negative Pressure.

Song liu

Electrospinning Advisor & Named Inventor on University of Manitoba Patents - PhD

Song Liu is a Professor of Polymer Chemistry and directs the Biomaterials Synthesis and Polymer Surface Engineering Laboratory at the University of Manitoba in Winnipeg, MB. Dr. Liu earned a Ph.D. in Fiber and Polymer Science at the University of California, Davis. Dr. Liu’s expertise lies in polymer/organic chemistry, biomaterials, nanotechnology and microbiology. The main focus of Dr. Liu’s research career is to approach the prevention and treatment of infectious diseases from the perspective of chemistry, nanotechnology and biomaterials. He has received over 1.97 M CAD in research funding as PI and 2.7 M CAD as Co-PI or collaborator from various granting agencies (including NSERC, CIHR, CFI and Research Manitoba) for his pioneering work in developing new broad-spectrum biocides, rechargeable biocidal coatings and “smart” polymeric materials. Dr. Liu is a member of the ParaNano Wound Care Scientific Advisory Board as biomaterial expert and research team. Dr. Liu is a named inventor on U.S. Patent 10,973,775 Antibacterial Nanofiber, and continuations US 17/227,940 Antibacterial Nanofiber and US 17/487,285 Color-Changing Antibacterial Nanofiber.

sarvesh logsetty

BURN CARE ADVISOR & NAMED INVENTOR ON UM PATENTS - MD

After graduating from the University of Alberta with a Bachelor of Science and M.D in 1990, Dr. Logsetty obtained his Diploma in Clinical Epidemiology from the University of Toronto in 1996. Dr. Logsetty completed the Surgical-Scientist Program at University of Toronto in 1994-1996. He continued his training in fellowships in Acute Burn Care & Reconstructive Surgery at Ross Tilley Burn Centre in Wellesley Hospital in Toronto, Ontario (1996-1998) and in Critical Care of Burns at Harborview Medical Centre in Seattle, Washington (1998-1999). He was appointed to the position of Associate Director of the Firefighters Burn Treatment Unit at the University of Alberta Hospital in 1999. In 2007 he was recruited by the University of Manitoba and the Health Sciences Centre to take on the position of Director of the new Burn Unit located at Health Sciences Centre in Winnipeg. He is currently Professor (Surgery, Psychiatry, and Children’s health) at the University of Manitoba. Dr. Logsetty holds certifications with The Royal College of Physicians and Surgeons and the American Board of Surgery. Dr. Logsetty holds memberships in many Medical and Scientific organizations and is widely published in many topics, including Burns and trauma, his chosen areas of interest. Research by Dr. Logsetty, his students, and burn team have won numerous national and international awards and have led to changes in clinical care. . Dr. Logsetty is a named inventor on U.S. Patent 10,973,775 Antibacterial Nanofiber, and continuations US 17/227,940 Antibacterial Nanofiber and US 17/487,285 Color-Changing Antibacterial Nanofiber.